Digistain logo (teal)
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
✕
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
Contact us

admin

  • Home
  • News
  • admin
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Awards
  • Conferences
  • Digistain
  • Funding
  • Healthcare
  • News
  • All
  • All
  • admin
October 2, 2022
WhatsApp Image 2022 10 24 at 05.14.42 3
October 2, 2022
Categories
  • Conferences

Digistain presenting @ TME 2022, Las Vegas USA

Digistain presented at TME 2022, Las Vegas.
Do you like it?
Read more
September 28, 2022
Innovate UK
September 28, 2022
Categories
  • Funding

Digistain wins Innovate UK SMART Grant

Absolutely beaming to learn that Innovate UK SMART committee chose to fund Digistain – This is one of UK’s most fiercely competitive funding calls and it’s […]
Do you like it?
Read more
September 13, 2022
esmo
September 13, 2022
Categories
  • Conferences

Proud to be presenting our clinical data at ESMO

The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.
Do you like it?
Read more
August 8, 2022
Eleven logo 02
August 8, 2022
Categories
  • Funding

Digistain is funded by Sofia Angels Ventures

Huge thanks to European Government backed Sofia Angels Ventures for their investment in Digistain. The €13M venture fund supported by European Investment Fund (EIF) for angel […]
Do you like it?
Read more
April 8, 2022
IMG 8495
April 8, 2022
Categories
  • Conferences

Digistain is invited to TME meeting in Vegas

TME is a network of clinicians, researchers, educators and companies whose core mission is to improve the quality and access to advanced targeted cancer care by […]
Do you like it?
Read more
March 16, 2022
01
March 16, 2022
Categories
  • Conferences

Digistain presents at ASBrS 2022

Digistain presenting our latest clinical data at the American Society of Breast Surgeons Meeting – Las Vegas. Together, we discussed the latest research, surgical innovations, and […]
Do you like it?
Read more
March 12, 2022
IMG 2322
March 12, 2022
Categories
  • Conferences

Digistain presents at NCoBC Vegas 2022

Proud to showcase our clinical data at the interdisciplinary conference – the National Consortium of Breast Cancers – Las Vegas This year’s program highlights the interdisciplinary […]
Do you like it?
Read more
September 10, 2021
dsv 1
September 10, 2021
Categories
  • Digistain

Darius Francescatti joining as advisor

Announcing our new team member – Darius Francescatti, a breast surgeon who brings to Digistain 20+ years of experience in breast cancer management. Prof Darius Francescatti […]
Do you like it?
Read more
August 30, 2021
Y Combinator Logo
August 30, 2021
Categories
  • Funding

DigiStain gets Y Combinator funding

Digistain took part in Y Combinator’s Summer 2021 cohort. “Since 2005, Y Combinator has funded over 3,000 companies and worked with over 6,000 founders. Every 6 […]
Do you like it?
Read more
Prev page
123456
Next page
Digistain

Digistain is a cancer biomarker company. Its breast cancer recurrence-risk test measures the tumour’s biochemistry directly, with results before the next appointment.

LRQA certified ISO 13485

Platform

  • Overview
  • How it works
  • Research and pipeline
  • Publications

Digistain Breast

  • Overview
  • For clinicians
  • For laboratories
  • For patients

Company

  • Partners
  • Investors
  • About
  • Team
  • News
  • Contact
© 2026 Digistain Ltd · ISO 13485:2016 certified (LRQA) for the design and development of IVD software used in cancer management · Privacy policy · Terms and conditions · Cookie policy